Global IVD Raw Materials Market 2023-2029

March 2023 | 69 pages | ID: G35359FA0E2DEN
Gen Consulting Company

Abstracts

In vitro diagnostic (IVD) raw materials are the components and substances that are used to manufacture diagnostic tests and assays that are used to identify infectious diseases, cancers, genetic disorders, and other medical conditions. The raw materials used in IVD production may vary depending on the type of test being developed, but they typically include antibodies, protein markers, enzymes, nucleic acids, buffers and reagents, others. The quality and purity of IVD raw materials are critical for the accuracy and sensitivity of diagnostic tests. Raw materials used in IVD production are typically manufactured under strict quality control and regulatory guidelines to ensure consistency and reproducibility. The global IVD raw materials market is anticipated to increase by USD 12.3 billion till 2029 at an average annual growth of 6.38 percent as per the latest market estimates.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global IVD raw materials market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, technology, end user, and region. The global market for IVD raw materials can be segmented by product: antibodies & antigens, enzymes, proteins, biological buffers, others. In 2022, the antibodies & antigens segment made up the largest share of revenue generated by the IVD raw materials market. IVD raw materials market is further segmented by technology: clinical chemistry, immunochemistry, molecular diagnostics, others. The clinical chemistry segment was the largest contributor to the global IVD raw materials market in 2022. Based on end user, the IVD raw materials market is segmented into: pharmaceutical, diagnostic laboratories, others. The pharmaceutical segment is estimated to account for the largest share of the global IVD raw materials market. On the basis of region, the IVD raw materials market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Europe held the largest share of the global IVD raw materials market in 2022 and is anticipated to hold its share during the forecast period.

Market Segmentation
By product: antibodies & antigens, enzymes, proteins, biological buffers, others
By technology: clinical chemistry, immunochemistry, molecular diagnostics, others
By end user: pharmaceutical, diagnostic laboratories, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Aalto Bio Reagents Ltd., Fapon Biotech Inc., Fujirebio Inc., Merck KGaA, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global IVD raw materials market.
To classify and forecast the global IVD raw materials market based on product, technology, end user, region.
To identify drivers and challenges for the global IVD raw materials market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global IVD raw materials market.
To identify and analyze the profile of leading players operating in the global IVD raw materials market.

Why Choose This Report
Gain a reliable outlook of the global IVD raw materials market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY PRODUCT

Antibodies & antigens
Enzymes
Proteins
Biological buffers
Others

PART 6. MARKET BREAKDOWN BY TECHNOLOGY

Clinical chemistry
Immunochemistry
Molecular diagnostics
Others

PART 7. MARKET BREAKDOWN BY END USER

Pharmaceutical
Diagnostic laboratories
Others

PART 8. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 9. KEY COMPANIES

Aalto Bio Reagents Ltd.
Fapon Biotech Inc.
Fujirebio Inc.
Merck KGaA
F. Hoffmann-La Roche AG
Thermo Fisher Scientific Inc.

DISCLAIMER